Ascendis Pharma · 3 days ago
Director, US Secondary Data Analytics and Field Insights - Job ID: USDA
Ascendis Pharma is a fast-growing biopharmaceutical company dedicated to improving patients' lives through innovative technology. The Director of Secondary Data Analytics & Field Insights will manage commercial analytics efforts, translating complex data into actionable strategies to enhance sales and marketing performance while mentoring a high-performing analytics team.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Analyze secondary data (IQVIA, Symphony, Komodo, claims, EMR, SP data) to understand HCP behavior, patient journeys, market dynamics, and brand performance
Lead territory optimization and alignment, sales force sizing/design, incentive plan modeling, alignments
Inform customer segmentation, targeting, omnichannel engagement, call planning, and sales force deployment
Prioritize and develop standard and ad hoc analysis to address key business questions
Develop structured feedback mechanisms from field teams and synthesize qualitative insights into actionable recommendations
Partner closely with Sales, Marketing, Forecasting and Market research, Market Access and Patient Services to ensure alignment between analytics and business needs
Collaborate cross-functionally with Forecasting, IT, Market Research, and external vendors to ensure data accuracy and consistency
Provide strategic recommendations through KPIs, dashboards (Power BI), and other reports to track performance, identify risks, and optimize execution
Support brands by enabling data and insight driven decision making through scenario modeling, forecasting inputs, and competitive assessments
Present insights and performance monitoring results for senior leadership to influence and drive business decisions
Identify and implement new tools, technologies, and best practices to drive innovation in commercial analytics
Qualification
Required
Bachelor's degree required; Master's degree (MS, MBA) in a quantitative or healthcare-related discipline strongly preferred
8-12 years of progressive experience in commercial analytics or insights within the pharmaceutical or biotech industry
Strong background in syndicated data (IQVIA, Symphony, Komodo) and patient-level claims/EMR analytics
Advanced analytical skills with strong business acumen and the ability to synthesize insights into clear recommendations
Experience in PowerBI and other data visualization platforms; SQL and Excel required, R/Python a plus
Proven ability to triangulate and synthesize complex data and insights to senior leaders in an effective way
Experience building forecasting models to reconcile strategic drivers for near-term performance and other qualitative and quantitative modalities
Exceptional data analysis skills with a deep understanding of market trends, competitor landscapes, and regulatory changes
Strong communicator with experience presenting complex insights to senior leadership
Proven ability to collaborate cross-functionally with teams
Proactive, detail-oriented, and skilled in identifying risks and opportunities
Continuous improvement mindset, focused on enhancing forecasting methodologies and processes
Ability to build and maintain strong relationships with key stakeholders across the organization
Entrepreneurial, highly accountable, and adaptable to shifting priorities and ambiguity
Knowledge of industry best practices, with a passion for leveraging new tools and technologies to improve efficiency
Benefits
401(k) plan with company match
Medical, dental, and vision plans
Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
Company-provided short and long-term disability benefits
Unique offerings of Pet Insurance and Legal Insurance
Employee Assistance Program
Employee Discounts
Professional Development
Health Saving Account (HSA)
Flexible Spending Accounts
Various incentive compensation plans
Accident, Critical Illness, and Hospital Indemnity Insurance
Mental Health resources
Paid leave benefits for new parents
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Recent News
2025-12-09
2025-12-01
2025-11-28
Company data provided by crunchbase